Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% year-on-year increase [2] Business Line Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Operating profit for the insurtech segment reached approximately CNY 180 million, marking a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [15][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring AI applications in non-insurance areas to support growth [4] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company has maintained GAAP profitability for 15 consecutive quarters since Q1 2022 [3] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million [5] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][17] - Operating profit for the insurtech business reached about CNY 180 million, a year-on-year increase of 44.3% [3][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][20] - WaterDrop C-Point AI, a low-code AI platform, was launched to enhance operational efficiency and support various business tasks [4][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company is committed to sustainable development and creating value for society through its initiatives [5] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - As of the end of September, the company held a cash position of about CNY 3.61 billion, ensuring financial support for business expansion [19] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - The company reported total revenue of CNY 975 million for Q3 2025, reflecting a year-on-year growth of 38.4% [2][16] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][18] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [6][16] - Operating profit for the insurtech segment reached approximately CNY 180 million, a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][16] Market Data and Key Metrics Changes - The medical profiling platform raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][12] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][18] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring applications of AI in non-insurance areas to support growth [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, supported by strong business performance [6] - The company emphasized the importance of AI in enhancing operational efficiency and decision-making capabilities [8][10] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, approximately 58.1 million ADS were repurchased in the open market, totaling $113 million [5] Q&A Session Summary Question: What are the expectations for future growth in the insurance business? - Management highlighted significant growth momentum in the insurance business, with a focus on optimizing real-time identification capabilities and enhancing product offerings [6][7] Question: How is the company addressing operational efficiency? - The company is deploying AI widely across operations, which has led to improved response times and increased productivity in various service scenarios [10][17]